Skip to main content
. 2023 Feb 14;27(3):609–616. doi: 10.1007/s10029-023-02755-6

Table 5.

Postoperative outcome measures

Total I (no risk factors) II (prehabilitated patients) p
n 259 133 126
SSO (n,%) 87 (34) 43 (32) 44 (35) 0.659
Seroma I–II (n,%) 22 (8) 9 (7) 13 (10) 0.306
Seroma III–IV (n,%) 19 (7) 10 (8) 9 (7) 0.908
Hematoma I–II (n,%) 28 (11) 12 (9) 16 (13) 0.341
Hematoma III–IV (n,%) 8 (3) 3 (2) 5 (4) 0.426
SSE 18 (7) 6 (5) 12 (10) 0.113
SSI 31 (12) 14 (11) 17 (13) 0.462
SSOPI 13 (5) 6 (5) 7 (6) 0.700
Systemic complications
 0 (n,%) 165 (64) 81 (61) 84 (67) 0.190
 1 (n,%) 60 (23) 31 (23) 29 (23)
 2 (n,%) 17 (7) 13 (10) 4 (3)
  > 2 (n,%) 17 (7) 8 (6) 9 (7)
Airway infection (n,%) 54 (21) 28 (21) 26 (21) 0.934
Pulmonary embolism (n,%) 6 (34) 5 (4) 1 (34) 0.113
Gastrointestinal (n,%) 24 (9) 10 (8) 14 (11) 0.319
Cardial (n,%) 10 (4) 7 (5) 3 (34) 0.229
Other complications (n,%) 45 (17) 24 (18) 21 (17) 0.769
Mortality (n,%) 4 (2) 3 (2) 1 (1) 0.340
Length of stay (median, QR) 6 (5–8) 6 (5–8) 6 (5–8) 0.401
Admission > 7 days (n,%) 57 (22) 27 (20) 30 (24) 0.496
Reoperation (n,%) 14 (5) 4 (3) 10 (8) 0.079
 Readmission (n,%) 12 (5) 4 (3) 8 (6) 0.201

SSO surgical site occurrence, seroma/hematoma I–II no clinical significance, seroma/hematoma III–IV clinical significance- needing intervention, SSE surgical site event, SSI surgical site infection, SSOPI surgical site occurrence requiring procedural interventions